AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...

The engine-turbocharger maker’s stock rose after it posted higher earnings, exceeded $1 billion in revenue for the first time ...

The engine-turbocharger maker’s stock rose after it posted higher earnings, exceeded $1 billion in revenue for the first time ...

Swiss duty-free retailer Avolta reported a slightly better-than-expected annual turnover on Wednesday, driven by growth ...

On's performance in the fourth quarter of 2024 was particularly impressive, with net sales growing by 35.7% year-on-year to 606.6 million Swiss francs (a 40.6% increase at constant exchange rates), ...

Performance fees increased by 38% to CHF 511 million (2023: CHF 369 million), representing 24% of total revenues (2023: 19%). The marked increase primarily resulted from successful exits and strong ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit that the Swiss pharma ...

Shareholders of Galderma Group AG are offering a 6.3% stake in the Swiss skincare group. Buyout group EQT AB, the Abu Dhabi ...

Deeper relationships with celebrity ambassadors and wholesale partners are in focus as the activewear brand grows sales by ...

With multiple wars on the brink of either peace or escalation, U.S.-China relations spiraling and global tariffs in play, ...